Single Cell Resolution for Safer Therapies and Better Outcomes
Genome integrity is essential for predicting therapeutic safety and patient outcomes, whether dealing with cell-based therapies or analyzing heterogeneous tumors. Traditional methods for assessing genome stability are often limited by low throughput or time-consuming clonal outgrowth processes.
Now, with Mission Bio’s Tapestri Genome Integrity Assay, comprehensively analyze genome-wide copy number variations (CNVs) across thousands of cells in a single assay. This powerful assay enables you to evaluate genome stability within cell therapies and detect aneuploidy in cancer clones with unmatched resolution and scale.
Genome Integrity Characterization of Genome-Edited Cell Therapies for Safety Assessment
Detect Genome Editing Outcomes with CNV
With the Tapestri single-cell platform you can obtain critical genome editing measurements alongside CNV analysis to validate your engineered cell therapy.
Tapestri Genome Integrity Assay
Everything you need to conduct single-cell multiomics analysis of genome-wide CNV.
- Tapestri Instrument
- Tapestri Single-cell Genome Integrity Solution including:
- DNA + Protein Core Kit
- Genome-Wide CNV Panel
- Custom-Designed or Catalog DNA Panel (+ Optional Protein Panel)
- Software-Based Analysis (via Portal Access or On-Premise Activation)
- Optional Sample Multiplexing
Explore Genome Integrity Services by Application
Single-Cell DNA Genome-Wide CNV Panel
- 500 amplicon panel uniformly covering nearly the entire genome
- Amplicons spaced average 5.8Mb apart
- Panel Uniformity: 96.7%
Dr. Teresa Davoli
Get Started
Contact us to begin your evaluation
*The content provided herein may relate to products that have not been fully validated by Mission Bio and is subject to change without notice. For Research Use Only. Not for use in diagnostic procedures.